Patented Medicine Prices Review Board

The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by regulating the prices of patented medicines sold in Canada, and by reporting on pharmaceutical trends.

We are an independent quasi-judicial body that is part of the Health portfolio, and operate at arm’s-length from the Minister of Health.

Department name

Follow:

We are in the process of moving our services and information to Canada.ca.

Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.

Latest news

PMPRB Draft Guidelines Consultation

Draft Guidelines Consultation

The PMPRB is accepting further written submissions from interested parties until March 18, 2020 to provide stakeholders with an opportunity to convey any new or different information.

Meds Entry Watch 2018

Meds Entry Watch 2018

This is the fourth edition of the PMPRB’s Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries. 

What we are doing

Corporate information

Features

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: